Organization’s 6,000-genome effort will power global ALS research through detailed long-read sequencing data made freely available to scientists worldwide NEW YORK and MENLO PARK, Calif. — Target ALS, a nonprofit breaking down barriers to amyotrophic lateral sclerosis (ALS) research, has partnered with PacBio (Nasdaq: PACB), a leading provider of high-quality, highly accurate long read sequencing platforms, to launch the largest global […]
The Medical Research Council Unit in The Gambia at the London School of Hygiene & Tropical Medicine and Oxford Nanopore are today celebrating the launch of their next generation nanopore Genomic Centre of Excellence Oxford Nanopore Technologies, the global company behind a new generation of nanopore-based molecular sensing technology and MRC Unit The Gambia (MRCG) […]
Following FDA approval last year, Illumina’s TSO Comprehensive test gains broad payer reimbursement, expanding access to comprehensive genomic profiling to match patients with targeted therapies Illumina’s IVD portfolio will also expand to offer Pillar oncoReveal® CDx, the newest panel to deliver critical companion diagnostic testing using the Illumina MiSeq™ Dx System SAN DIEGO — Illumina Inc. (NASDAQ: ILMN) today […]
Seasoned Life Sciences Executive to Guide Accelerated Growth SAN DIEGO — Genesee Scientific, a leading provider of laboratory essentials for the life sciences industry, is pleased to announce the elevation of Jeff Jochims’ role to Executive Chair of the Board. Jochims has served as a member of Genesee’s Board of Directors since 2023 and has over 25 […]
New technology has potential to accelerate timelines for therapeutic research and drug development SAN DIEGO — Telesis Bio Inc. (OTCMKTS: TBIO), a leading provider of DNA and mRNA synthesis solutions to accelerate therapeutic discovery with fast and flexible on-site automated foundries, today announced a new license agreement with Regeneron Pharmaceuticals, Inc. to deploy Telesis Bio’s […]
Company to highlight continuous innovation, pharma partnership, and commitment to advancing cancer care through poster presentations and booth demos CARLSBAD, Calif. — Thermo Fisher Scientific, the world leader in serving science, will showcase some of the technologies that have helped power precision oncology at the 2025 American Society of Clinical Oncology (ASCO) Annual Meeting. Through […]
SANTA CLARA, Calif. — Agilent Technologies Inc. (NYSE: A) today announced August Specht, Ph.D., has been named the company’s Chief Technology Officer. Specht, previously vice president of Global R&D for the Chromatography and Mass Spectrometry Division at Thermo Fisher Scientific, will join Agilent on June 9. “We are thrilled to welcome August Specht to the […]
ZURICH — BC Platforms, a technology company pioneering the future of global Real-World Data (RWD) excellence, today announced the appointment of Keith Collier as Chief Product Officer and Michele Lichtenfield as EVP & Head of Global Marketing. Keith and Michele will work with other senior leaders to expand the Company’s global impact and deliver groundbreaking products that redefine the future of scalable and […]
Pillar Biosciences, Inc., the leader in Decision Medicine™, today announced they have received $34.5M in funding, including a strategic investment from Illumina, and structured financing from Soleus Capital and investments from existing investors. Proceeds from this financing will be leveraged to advance Pillar’s commercial activities including headcount and infrastructure to support biopharma partnerships and expand adoption […]
Milan, Italy – MGI Tech Co., Ltd. (“MGI”), a company dedicated to developing core tools and technologies that drive innovation in life sciences, unveiled cutting-edge multi-omics technologies at the European Society of Human Genetics (ESHG) 2025 conference in Milan. At Booth #310, MGI highlighted its advanced sequencing and automation platforms, including the new mid-throughput sequencer […]
Pay Invoice
Latest Blogs
-
MOBILion Expands into Proteomics MS Market
April 30, 2026 5:05 pm
-
Carterra Introduces Faster SPR
March 27, 2026 7:26 pm
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
